XML 60 R46.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK BASED COMPENSATION (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of stock-based compensation expense

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the condensed consolidated statements of operations as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

​

​

2021

    

2020

Research and development

​

$

916

​

$

713

General and administrative expense

​

 

839

​

 

237

Sales and marketing expense

​

 

345

​

 

209

Cost of sales

​

 

117

​

 

100

Total stock-based compensation expenses

​

$

2,217

​

$

1,259

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the consolidated statements of operations as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

Years Ended December 31, 

​

    

2020

    

2019

Research and development

​

$

3,276

​

$

2,713

General and administrative expense

​

 

3,464

​

 

941

Sales and marketing expense

​

 

894

​

 

1,373

Cost of sales

​

 

372

​

 

188

Total stock-based compensation expenses

​

$

8,006

​

$

5,215

Schedule of option activity

There were 14,140,956 shares available for award under the 2020 Plan at March 31, 2021. The option activity of the Plans for the three months ended March 31, 2021, is as follows (shares in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted-Average 

 

​

​

​

​

​

​

Weighted-Average 

​

Remaining 

 

Aggregate

​

​

Number of 

​

Exercise Price 

​

Contractual Term 

 

Intrinsic Value

​

    

Shares

    

per Share

    

(in years)

 

(in thousands)

Outstanding at January 1, 2021

​

19,553

​

$

1.53

​

7.75

​

$

306,408

Granted

 

—

​

$

—

 

​

​

​

​

Exercised

 

(163)

​

$

1.10

 

​

​

​

​

Forfeited/expired

 

(12)

​

$

1.40

 

​

​

​

​

Outstanding at March 31, 2021

 

19,378

​

$

1.53

 

7.51

​

$

259,023

Options vested at March 31, 2021

 

11,044

​

$

1.55

 

6.29

​

$

147,481

Options vested or expected to vest at March 31, 2021

 

18,673

​

$

1.54

 

7.45

​

$

249,529

There were 14,379,052 shares available for award under the 2020 Plan at December 31, 2020. The option activity of the 2015 Plan and Make Plan for the year ended December 31, 2020, is as follows (shares in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted-Average 

 

​

​

​

​

​

​

Weighted-Average 

​

Remaining 

 

Aggregate

​

​

Number of 

​

Exercise Price 

​

Contractual Term 

 

Intrinsic Value

​

    

Shares

    

per Share

    

(in years)

 

(in thousands)

Outstanding at January 1, 2020

​

18,072

​

$

2.01

​

7.84

​

$

24,045

Granted

 

8,463

​

$

1.51

 

​

​

​

​

Exercised

 

(522)

​

$

0.62

 

​

​

​

​

Forfeited/expired

 

(6,460)

​

$

2.92

 

​

​

​

​

Outstanding at December 31, 2020

 

19,553

​

$

1.53

 

7.75

​

$

306,408

Options vested at December 31, 2020

 

10,905

​

$

1.53

 

6.52

​

$

170,868

Options vested or expected to vest at December 31, 2020

 

18,818

​

$

1.53

 

7.69

​

$

294,824

Schedule of RSU activity

​

​

​

​

​

​

​

​

Shares Subject 

    

Weighted-Average

​

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2021

​

683

​

$ 8.02

Granted

​

250

​

$ 30.49

Vested

​

(15)

​

$ 8.19

Balance of unvested shares as of March 31, 2021

​

918

​

$ 14.14

​

​

​

​

​

​

​

​

Shares subject 

    

Weighted Average

​

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2020

​

—

​

—

Granted

​

683

​

$ 8.02

Vested

​

—

​

—

Balance of unvested shares as of December 31, 2020

​

683

​

$ 8.02

Consultant    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of assumptions using Black-Scholes option-pricing model

​

​

​

​

​

​

​

​

Three Months Ended

​

​

​

March 31, 2020

​

Risk‑free interest rate

​

​

0.8

%

Expected volatility

​

​

54.3

%

Expected life (in years)

​

​

10.0

​

Expected dividend yield

​

​

—

​

Fair value of Common Stock

​

$

3.34

​

​

​

​

​

​

​

​

​

​

​

​

Years Ended December 31, 

​

​

    

2020

    

2019

​

Risk‑free interest rate

​

​

0.6% – 0.8

%

​

1.4% – 3.1

%

Expected volatility

​

 

54.3% – 54.8

%

 

52.4% – 61.5

%

Expected life (in years)

​

 

9.4 – 10.0

​

 

6.2 – 10.0

​

Expected dividend yield

​

 

—

​

 

—

​

Fair value of Common Stock

​

$

1.40 – 7.98

​

$

3.34

​

Employee    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of assumptions using Black-Scholes option-pricing model

​

​

​

​

​

​

​

​

Three Months Ended

 

​

​

March 31, 2020

 

Risk‑free interest rate

​

​

0.7 % – 0.9

%

Expected volatility

​

​

52.7 % – 52.9

%

Expected life (in years)

​

​

5.9 – 6.1

​

Expected dividend yield

​

​

—

​

Fair value of Common Stock

​

$

3.34

​

​

​

​

​

​

​

​

​

​

​

​

Years Ended December 31, 

 

​

    

2020

    

2019

 

Risk‑free interest rate

​

​

0.3% – 1.7%

%

​

1.7% – 2.6

%

Expected volatility

​

 

52.7% – 54.2

%

​

52.7% – 53.6

%

Expected life (in years)

​

 

5.9 – 6.3

 

​

5.6 – 6.1

​

Expected dividend yield

​

 

—

 

​

—

​

Fair value of Common Stock

​

$

1.40 – 7.98

 

$

3.34

​